Conference Reports

VasCog 2018 (9th International Conference of The International Society of Vascular Behavioural and Cognitive Disorders)

14 November 2018 - 17 November 2018

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!

Evolocumab scores big in paediatric HeFH

Elvira Manzano, 3 days ago

Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.

Weight loss by either surgery or diet key to better metabolic health in diabetes

Jairia Dela Cruz, 3 days ago

For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.